Symbol
| IL17A
| contributors: mct/shn - updated : 02-03-2016
|
HGNC name
| interleukin 17A
|
HGNC id
| 5981
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in the invasive group of pituitary adenomas (pMID: 21279695) | |
Susceptibility
|
to rheumatoid arthritis |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| novel indicator of prognosis in the patients with colorectal carcinoma | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | digestive | colon | |
could serve as a novel therapeutic target for colorectal carcinoma | cancer | digestive | colon | |
IL17A and IL17RA are therapeutic targets in colorectal cancer |
| | |
| IL-17-deficient mice display contact, delayed-type, and airway hypersensitivity responses, and reduced T-dependent antibody production | |
IL-17-deficient mice exhibit a markedly suppressed collagen-induced arthritis |
|
Mice deficient in IL-17A demonstrated delayed healing and decreased IL-17A production after skin infection with C. albicans |